This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 14, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel



Older grandfathers pass on telomeres, possibly longer life
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Was your grandfather already advanced in age when your father was born? If so, your DNA may help you live longer, Northwestern University scientists reported. The reason for the seemingly counterintuitive effect? Older fathers have children with longer telomeres. Telomeres are bits of DNA at the end of chromosomes that impact aging and cell death. Generally, the longer your telomeres, the longer you live. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.

Skinny genes: DNA diet plans spreading
ELLE    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Elite new diet programs promise more effective weight loss with plans so personal they're based on your genetic response to food and exercise. Is this a true scientific breakthrough, or just another way to waste your precious time and money? More

Gene search throws up 4 inherited clues to migraines
Agence France-Presse via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
European and Australian scientists said they had snared four more genes that highlight an inherited cause for common migraine. The genetic variants were spotted in a trawl through the DNA code of 4,800 people with a history of "migraine without aura," which accounts for two-thirds of migraine attacks. More

Gene mutations may predict breast cancer treatment response
HealthDay News via Doctors Lounge    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genetic mutations present in women with breast cancer may be able to predict whether the tumor will respond to treatment, according to a study published online in Nature. Researchers identified 18 significantly mutated genes in tumors, including five genes which had already been associated with hematopoietic disorders. More

 Biotech/Diagnostics/Personalized Medicine

Reprogramming cells could eliminate dangers of medicine side effects
U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Recent drugs that have been created can help treat some of the toughest diseases, from Alzheimer's and Parkinson's to all types of cancers. The only problem: They kill some people. But new breakthroughs in cell engineering might usher in a new era of personalized medicine where drugs can be tested for side effects without having to test the drug in humans. More


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

1st trial of vaccine to treat Parkinson's disease begins
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Funded by the Michael J. Fox Foundation, an Austrian company is testing the safety and tolerability of PD01A, the vaccine for Parkinson's disease. There are already treatments for Parkinson's; however, this is the first to actually target the disease process itself. More

Umbilical cord stem cells provide life-saving treatment for children
ARA Content via Journal Sentinel    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When expectant parents imagine their children's future, chances are that a rare genetic disorder is not part of that picture. Emerging scientific research on cord blood stem cells shows promise in filling treatment gaps for many children who face certain life-threatening conditions. More

 Emerging Medical Technologies

House votes to repeal tax on medical devices
Agence France-Presse via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. House of Representatives ignored a White House veto threat and voted to repeal a tax on medical devices, an element of President Barack Obama's healthcare law which Republicans say kills jobs and hinders innovation. More

Atrial fibrillation detection app shaping up, awaiting FDA approval
Medgadget    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Worcester Polytechnic Institute researchers have developed a cardiac app that aims to detect not only the heart rate, but also heart rhythm, respiration rate and blood oxygen saturation. The app — which uses a smartphone's camera and light-source to detect small changes in skin color — is expected to hit the market in three to six months, pending FDA approval. More

 Managed Healthcare News

Seniors missing out on some new Medicare benefits
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Thus far, just 1 percent of Medicare beneficiaries who live in Hawaii, or 890 people, have used the benefit in 2012, the lowest percent of any state, according to figures from the Centers for Medicare & Medicaid Services. In contrast, about 8 percent of seniors in Rhode Island have taken advantage of wellness visits in the first five months of 2012, the most of any state. More

Only 7 states, D.C. expand Medicaid ahead of 2014
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Only seven states and Washington, D.C., have decided to cover more adults before the 2014 Medicaid program extension. The goal of the Obama administration's healthcare law is to provide Medicaid to all people with incomes up to 133 percent of the federal poverty level. The seven states are California, Colorado, Connecticut, Minnesota, Missouri, New Jersey and Washington. More

 FDA: New Treatments and Technology

Experts raise questions on safety of 'spray-on' tans
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefThe active chemical used in spray tans, dihydroxyacetone, has the potential to cause genetic alterations and DNA damage, according to a panel of medical experts who reviewed 10 publicly available scientific studies. Six medical experts in areas ranging across the fields of dermatology, toxicology and pulmonary medicine said they "have concerns" after reviewing the literature and reports about DHA, the main chemical in the popular "spray-on" tan. More

Roche's breast cancer drug gets FDA nod
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The new injectable drug, Perjeta, is used for HER-2 positive breast cancer treatment. This type of cancer was previously incurable. The drug was given priority review which means the agency believes the drug may represent a potentially significant advancement over other treatments. It has been proven to keep cancer from worsening for six extra months. More

"Roughly 50,000 to 60,000 new cases of Parkinson's Disease are diagnosed each year, according to the National Parkinson Foundation. The Centers for Disease Control and Prevention rated complications from Parkinson's as the U.S.'s 14th leading cause of death."
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 7, 2012
May 31, 2012
May 24, 2012
May 17, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063